Maverix Medical, a dedicated lung cancer platform established by Ajax Health, KKR, and Hologic, Inc., announced the acquisition of Cirrus Bio for an ...
GE HealthCare (Nasdaq: GEHC) announces the U.S. FDA 510(k) Clearance of IONIC Health’s revolutionary nCommand Lite technology, aimed at mitig...
In 2023, Beckman Coulter and Fujirebio entered into a collaboration agreement focused on new biomarkers aligned with recently approved monoclonal a...
For over three decades, LOGIQ has been at the forefront of ultrasound imaging, providing clinicians with reliable, high-quality solutions. The latest...
CMR Surgical (CMR), a global leader in surgical robotics, has announced the appointment of Sushobhan Dasgupta as President and Chief Commercial Officer for...
PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion...
Viz.ai, a pioneering force in AI-driven disease detection and intelligent care coordination, has attained a significant milestone with the receipt ...
Carcinotech has raised $5.3 million of funding as the company looks to build on its traction in the UK and Europe, with US expansion planned later this yea...
Nikon Instruments Inc. (Nikon) is pleased to announce the establishment of the Nikon BioImaging Lab Lexington in Massachusetts, USA, where it will provide ...
-DNAnexus, Inc., the provider of the Precision Health Data Cloud, and TMA Precision Health, a global health platform for rare diseases, announced a collabo...
In a significant move, Agappe and Fujirebio have revealed plans to launch these products in June 2024. The project has already achieved significant progres...
Neuralace Medical, Inc., an innovator in pain management technology, proudly announces the FDA clearance of its groundbreaking product, Axon Therapy ...
-DNAnexus, Inc., the provider of the Precision Health Data Cloud, and Intelliseq, a genome informatics company and innovative provider of next-generation s...
HORIBA Medical has launched the new HELO 2.0 high throughput automated hematology platform which is CE-IVDR approved. Following the su...
© 2025 Biopharma Boardroom. All Rights Reserved.
